首页> 美国卫生研究院文献>Journal of the Endocrine Society >SUN-189 A Case of Delayed Hypoaldosteronism Following Unilateral Adrenalectomy for Primary Aldosteronism
【2h】

SUN-189 A Case of Delayed Hypoaldosteronism Following Unilateral Adrenalectomy for Primary Aldosteronism

机译:Sun-189针对原代醛固烯症单侧肾上腺切除术后延迟低恶蛋白表达的情况

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Hypoaldosteronism occurs in 6–30% of patients following unilateral adrenalectomy for primary aldosteronism. The Endocrine Society guidelines recommend discontinuing potassium supplementation and spironolactone postoperatively with repeat renin and aldosterone after surgery to monitor for cure. Clinical Case: A 69-year-old male with a 15-year history of hypertension on amlodipine 10 mg daily, atenolol 100 mg daily, terazosin 5 mg daily, valsartan 160 mg daily, spironolactone 50 mg three times daily, with longstanding hypokalemia on potassium chloride 20 mEq four times daily presented with an ischemic stroke and persistent hypertension (BP 182/79). Following discontinuation of spironolactone, evaluation revealed aldosterone concentration of 214 ng/dL (normal 4.0 - 31) and plasma renin activity of 0.1 ng/mL/hr (normal 0.5 - 4.0), giving an aldosterone-to-renin ratio of 2,140. CT of the abdomen showed a 3 cm right adrenal mass. He underwent uncomplicated right adrenalectomy for primary aldosteronism. Postoperative potassium was 3.4 mEq/L (normal 3.5–5.0) and hypertension persisted, so he was discharged on potassium chloride 10 mEq, losartan 100 mg daily, amlodipine 10 mg daily, and labetalol 200 mg twice daily. Two weeks later potassium level was 5.1 mEq/L and potassium chloride supplement was discontinued. Six months postoperatively, potassium was 5.7 mEq/L with well-controlled blood pressure, so losartan was discontinued. Labs over the subsequent several weeks showed persistent hyperkalemia up to 6.2 mEq/L and new hyponatremia to 128 mEq/L (normal 134 - 150). Repeat plasma renin activity was 0.51 ng/mL/hr and aldosterone concentration <1.0 ng/dL. Morning cortisol concentration was 18.3 ug/dL (normal 6.7 - 22.6) and ACTH 38 pg/mL (normal 6.0 - 50 pg/mL). He was diagnosed with postsurgical hypoaldosteronism. Potassium stabilized at 5.1 mEq/L and sodium stabilized at 134 mEq/L, so he was monitored without treatment for hypoaldosteronism. One year postoperatively his labs showed: potassium 5.1 mEq/L, sodium 135 mEq/L, renin 1.0 ng/mL/hr, and aldosterone 5.7 ng/dL. Conclusion: This patient had primary aldosteronism leading to suppression of aldosterone secretion from the contralateral healthy adrenal gland. This resulted in postoperative hypoaldosteronism once the affected adrenal gland was resected. This case demonstrates the need for continued monitoring of potassium, sodium, renin, and aldosterone following unilateral adrenalectomy for primary aldosteronism, especially in the setting of postoperative angiotensin receptor blocker use or other medications which can affect the renin-angiotensin-aldosterone system.
机译:背景:醛固酮减少以下为原发性醛固酮增多症单侧肾上腺发生在患者的6-30%。内分泌学会的指南建议手术治疗后重复肾素和醛固酮停止补充钾和安体舒通术后监视治疗。临床病例:一名69岁的男性,高血压对氨氯地平有15年历史的每天10毫克,阿替洛尔每日100mg,特拉唑嗪5毫克,每日,缬沙坦160毫克每天,安体舒通50 mg,每天三次,对长期低血钾氯化钾20分当量每日四次带有缺血性中风和持续性高血压(BP79分之182)。以下安体舒通的终止,评价显示214毫微克/分升(正常4.0 - 31)的醛固酮浓度和血浆肾素0.1毫微克/毫升/小时(0.5标准 - 4.0)的活性,给出2140醛固酮对肾素比。腹部CT显示3cm的右肾上腺质量。他接受了简单的右肾上腺为原发性醛固酮增多症。术后钾为3.4毫当量/升(正常3.5-5.0)和高血压继续存在,因此他在氯化钾每日10毫克10排出毫当量,氯沙坦每日100mg,氨氯地平,和每日两次拉贝洛尔200毫克。两周后钾水平为5.1毫克当量/ L和氯化钾补充被中断。六个月后,氢为5.7毫当量/升具有良好控制血压,所以氯沙坦被中断。在随后的几周实验室呈持续性高钾血症高达6.2毫克当量/ L和新低钠血症至128毫当量/升(正常134 - 150)。肾素活性重复等离子体为0.51毫微克/毫升/小时和醛固酮浓度<1.0纳克/升。早晨皮质醇浓度为18.3微克/分升(正常6.7 - 22.6)和ACTH 38皮克/毫升(通常6.0 - 50皮​​克/毫升)。他被诊断为术后醛固酮减少症。钾稳定在5.1毫当量/升和钠在134毫当量/升稳定的,所以他不经治疗醛固酮减少监控。术后1年他的实验室发现:钾5.1毫克当量/ L,钠135毫克当量/ L,肾素1.0纳克/毫升/小时,和醛甾酮5.7纳克/升。结论:这名患者有原发性醛固酮增多症从健侧肾上腺导致醛固酮分泌的抑制。这导致醛固酮减少术后一旦受影响肾上腺切除了。这种情况下展示按照对原发性醛固酮增多症单侧肾上腺需要继续监测的钾,钠,肾素和醛甾酮,特别是在术后血管紧张素受体阻断剂的使用或其他药物可影响肾素 - 血管紧张素 - 醛固酮系统的设置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号